Health Condition 1: N72- Inflammatory disease of cervix uteri
Conditions
Interventions
Intervention1: Dexmedetomidine: 1mcg/kg
Intra venous administration.
Frequency: Once
Duration of therapy: Less than or equal to one hour.
Control Intervention1: Fentanyl: 2mcg/kg
Intravenous administr
Sponsors
Dr Madhumitha Vijay
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age group from 18 to 60 2.ASA 1 - ASA 2
Exclusion criteria
Exclusion criteria: 1. BMI 30 2.Patient with cardiac pathology 3.Known allergy to Propofol, Dexmedetomidine and Fentanyl. 4.Chronic hypertension 5.Patient with cardiac pathology 6.Chronic opioid treatment (Patient receiving sedation or analgesia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of Propofol-Dexmedetomidine versus Propofol-Fentanyl in terms of recovery time.Timepoint: Intra operative and Post operative. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the time taken for eye opening after last dose of Propofol in both the groups. To compare the incidence of post operative nausea and vomiting in both the groups. To compare the haemodynamic stability of the patients in both the groups. To compare the number of Propofol top ups needed for the patients in both the groupsTimepoint: Intra operative and Post operative | — |
Countries
India
Contacts
Public ContactMadhumitha Vijay
Shri Sathya Sai medical college and research centre
Outcome results
None listed